Medical device recalls Moderate risk

Roche Diagnostics Corporation recalls Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum a…

Recall date
March 18, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1194-2019
FDA classification
Class II
Brand / firm
Roche Diagnostics Corporation
Sold / distributed
US Nationwide distribution in the states of: GA, IL, KY, MI, and TX.

Why it was recalled

The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum and plasma on Roche/Hitachi cobas c systems.

Get recall alerts

Free email alert whenever Roche Diagnostics Corporation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Roche Diagnostics Corporation